Delving into the Latest Updates on SY002(Beijing Jiacheng) with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms

SY002

Target-

Action-

Mechanism-

Therapeutic Areas

Nervous System DiseasesOther Diseases

Active Indication

Analgesia

Inactive Indication-

Originator Organization

Beijing Jiacheng Biomedical Technology Development Co., Ltd

Active Organization

Beijing Jiacheng Biomedical Technology Development Co., Ltd

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

探索SY002片在人体内的PK特征，比较SY002片与对照制剂在人体内药代动力学的差异。研究受试制剂SY002片和对照制剂在健康成人受试者中的安全性（包括不良事件、严重不良事件、生命体征、体格检查、实验室检查、12导联心电图等检查）。

[Translation]

Explore the PK characteristics of SY002 tablets in humans and compare the differences in pharmacokinetics between SY002 tablets and control preparations in humans. Study the safety of the test preparation SY002 tablets and control preparations in healthy adult subjects (including adverse events, serious adverse events, vital signs, physical examinations, laboratory tests, 12-lead electrocardiograms, etc.).

Start Date10 Dec 2024

Sponsor / Collaborator

Beijing Jiacheng Biomedical Technology Development Co., Ltd

100 Clinical Results associated with SY002(Beijing Jiacheng)

Login to view more data

100 Translational Medicine associated with SY002(Beijing Jiacheng)

Login to view more data

100 Patents (Medical) associated with SY002(Beijing Jiacheng)

Login to view more data

100 Deals associated with SY002(Beijing Jiacheng)

Login to view more data